يعرض 1 - 10 نتائج من 394 نتيجة بحث عن '"D. A. Romanov"', وقت الاستعلام: 1.31s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    المصدر: Вавиловский журнал генетики и селекции, Vol 24, Iss 6, Pp 673-682 (2020)

    مصطلحات موضوعية: aphids, endosymbionts, pcr, plant pests, mutualism, Genetics, QH426-470

    وصف الملف: electronic resource

  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المصدر: Urology Herald; Том 11, № 1 (2023); 159-164 ; Вестник урологии; Том 11, № 1 (2023); 159-164 ; 2308-6424 ; 10.21886/2308-6424-2023-11-1

    وصف الملف: application/pdf

    العلاقة: https://www.urovest.ru/jour/article/view/681/457Test; Erdil H. Congenital anomalies of the kidneys in family members. Ann Saudi Med. 2003;23(3-4):231-2. DOI:10.5144/0256-4947.2003.231; Bae KS, Jeon SH, Lee SJ, Lee CH, Chang SG, Lim JW, Kim JI. Complete duplication of bladder and urethra in coronal plane with no other anomalies: case report with review of the literature. Urology. 2005;65(2):388. DOI:10.1016/j.urology.2004.08.043; Sindjic S, Perovic SV, Djinovic RP. Complex case of urethral duplication with megalourethra. Urology. 2009;74(4):903-5. DOI:10.1016/j.urology.2008.12.040; Effmann EL, Lebowitz RL, Colodny AH. Duplication of the urethra. Radiology. 1976;119(1):179-85. DOI:10.1148/119.1.179; Каганцов И.М., Санников И.А., Головин А.В., Сварич В.Г. Редкий вариант удвоения уретры у мальчика. Вестник урологии. 2020;8(2):107-112. DOI:10.21886/2308-6424-2020-8-2-107-112; Bar-Moshé O, Oboy G, Timmermans C, Vandendris M. Megalourethra and abnormalities of the cavernous bodies: cause of erectile dysfunction. Eur Urol. 1995;27(3):249-51. DOI:10.1159/000475171; Podesta ML, Medel R, Castera R, Ruarte AC. Urethral duplication in children: surgical treatment and results. J Urol. 1998;160(5):1830-3. DOI:10.1016/s0022-5347(01)62427-3; https://www.urovest.ru/jour/article/view/681Test

  8. 8
    دورية أكاديمية

    المصدر: Head and Neck Tumors (HNT); Том 13, № 1 (2023); 116-125 ; Опухоли головы и шеи; Том 13, № 1 (2023); 116-125 ; 2411-4634 ; 2222-1468 ; 10.17650/2222-1468-2023-13-1

    وصف الملف: application/pdf

    العلاقة: https://ogsh.abvpress.ru/jour/article/view/874/578Test; Are C., Shaha A.R. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 2006;13(4):453–64. DOI:10.1245/ASO.2006.05.042; Smallridge R.C., Ain K.B., Asa S.L. et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid 2012;22(11):1104–39. DOI:10.1089/thy.2012.0302.; Untch B.R., Olson J.A. Jr. Anaplastic thyroid carcinoma, thyroid lymphoma, and metastasis to thyroid. Surg Oncol Clin N Am 2006;15(3):661–79. DOI:10.1016/j.soc.2006.05.006; Sherman S.I. Anaplastic carcinoma: clinical aspects. In: Thyroid cancer: a comprehensive guide to clinical management. Ed. by L. Wartofsky, D. Van Nostrand. 2nd edn. Totowa: Humana Press, 2006. Pp. 629–632.; Venkatesh Y.S., Ordonez N.G., Schultz P.N. et al. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 1990;66(2):321–30. DOI:10.1002/1097-0142(19900715)66:23.0.co;2-a; Пылев А.Л., Жандарова А.А., Петров К.С. и др. Анапластический рак щитовидной железы. Есть ли свет в конце туннеля? Опухоли головы и шеи 2020;10(1):10–9. DOI:10.17650/2222- 1468-2020-10-1-10-19; Никифорович П.А., Румянцев П.О., Слепцов И.В. и др. Лечение BRAFV600E-позитивного рака щитовидной железы. Клиническое наблюдение. Сибирский онкологический журнал 2020;19(5):131–44. DOI:10.21294/1814-4861-2020-19-5-131-144; Subbiah V., Kreitman R.J., Wainberg Z.A. et al. Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600-mutant anaplastic thyroid cancer. J Clin Oncol 2018;36(1):7–13. DOI:10.1200/JCO.2017.73.6785; Marabelle A., Fakih M., Lopez J. et al. Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study. Lancet Oncol 2020;21(10):1353–65. DOI:10.1016/S1470-2045(20)30445-9; Capdevila J., Wirth L.J., Ernst T. et al. PD-1 blockade in anaplastic thyroid carcinoma. J Clin Oncol 2020;38(23):2620–7. DOI:10.1200/JCO.19.02727; Ma M., Lin B., Wang M. et al. Immunotherapy in anaplastic thyroid cancer. Am J Transl Res 2020;12(3):974–88.; Zwaenepoel K., Jacobs J., De Meulenaere A. et al. CD70 and PD-L1 in anaplastic thyroid cancer-promising targets for immunotherapy. Histopathology 2017;71(3):357–65. DOI:10.1111/his.13230; Cantara S., Bertelli E., Occhini R. et al. Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer. Endocrine 2019;64(1):122–9. DOI:10.1007/s12020-019-01865-5; Tuccilli C., Baldini E., Sorrenti S. et al. CTLA-4 and PD-1 ligand gene expression in epithelial thyroid cancers. Int J Endocrinol 2018;2018:1742951. DOI:10.1155/2018/1742951; Bible K.C., Kebebew E., Brierley J. et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid 2021;31(3):337386. DOI:10.1089/thy.2020.0944; Chiu A.C., Delpassand E.S., Sherman S.I. Prognosis and treatment of brain metastases in thyroid carcinoma. J Clin Endocrinol Metab 1997;82(11):3637–42. DOI:10.1210/jcem.82.11.4386; Salvati M., Frati A., Rocchi G. et al. 2001 Single brain metastasis from thyroid cancer: report of twelve cases and review of the literature. J Neurooncol 51(1):33–40. DOI:10.1023/a:1006468527935; D’Andrea M.A., Reddy G.K. Systemic antitumor effects and abscopal responses in melanoma patients receiving radiation therapy. Oncology 2020;98(4):202–15. DOI:10.1159/000505487; https://ogsh.abvpress.ru/jour/article/view/874Test

  9. 9
    دورية أكاديمية

    المساهمون: The study was financially supported by Russian Foundation for Basic Research (RFBR) grant 21-515-12007. The investigation has not been sponsored, Исследование было проведено при финансовой поддержке грантом РФФИ 21-515-12007. Исследование не имело спонсорской поддержки

    المصدر: Neurology, Neuropsychiatry, Psychosomatics; Vol 15, No 3 (2023); 27-34 ; Неврология, нейропсихиатрия, психосоматика; Vol 15, No 3 (2023); 27-34 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2023-3

    وصف الملف: application/pdf

    العلاقة: https://nnp.ima-press.net/nnp/article/view/2026/1532Test; Sadock BJ, Sadock VA, Ruiz P, eds. Kaplan and Sadock’s comprehensive textbook of psychiatry. 10th ed. Philadelphia: Wolters Kluwer; 2017.; Gao B, Wang Y, Liu W, et al. Spontaneous Activity Associated with Delusions of Schizophrenia in the Left Medial Superior Frontal Gyrus: A Resting-State fMRI Study. PLoS One. 2015;10(7):e0133766. doi:10.1371/journal.pone.0133766; Vicens V, Radua J, Salvador R, et al. Structural and functional brain changes in delusional disorder. Br J Psychiatry. 2016;208(2):153-9. doi:10.1192/bjp.bp.114.159087; Li T, Wang Q, Zhang J, et al. Brain-Wide Analysis of Functional Connectivity in First-Episode and Chronic Stages of Schizophrenia. Schizophr Bull. 2017;43(2):436-48. doi:10.1093/schbul/sbw099; Ferri J, Ford JM, Roach BJ, et al. Restingstate thalamic dysconnectivity in schizophrenia and relationships with symptoms. Psychol Med. 2018;48(15):2492-9. doi:10.1017/S003329171800003X; Chen X, Duan M, He H, et al. Functional abnormalities of the right posterior insula are related to the altered self-experience in schizophrenia. Psychiatry Res Neuroimaging. 2016;256:26-32. doi:10.1016/j.pscychresns.2016.09.006; Orliac F, Naveau M, Joliot M, et al. Links among resting-state default-mode network, salience network, and symptomatology in schizophrenia. Schizophr Res. 2013;148(1-3):74-80. doi:10.1016/j.schres.2013.05.007; Csukly G, Szabo A, Polgar P, et al. Fronto-thalamic structural and effective connectivity and delusions in schizophrenia: a combined DTI/DCM study. Psychol Med. 2021 Sep;51(12):2083-93. doi:10.1017/S0033291720000859. Epub 2020 Apr 24.; Limongi R, Mackinley M, Dempster K, et al. Frontal-striatal connectivity and positive symptoms of schizophrenia: implications for the mechanistic basis of prefrontal rTMS. Eur Arch Psychiatry Clin Neurosci. 2021;271(1):3-15. doi:10.1007/s00406-02001163-6; Arjmand S, Kohlmeier KA, Behzadi M, et al. Looking into a Deluded Brain through a Neuroimaging Lens. Neuroscientist. 2021;27(1):73-87. doi:10.1177/1073858420936172; Joyce EM. Organic psychosis: The pathobiology and treatment of delusions. CNS Neurosci Ther. 2018;24(7):598-603. doi:10.1111/cns.12973; Darby RR, Laganiere S, Pascual-Leone A, et al. Finding the imposter: brain connectivity of lesions causing delusional misidentifications. Brain. 2017;140(2):497-507. doi:10.1093/brain/aww288; Gurin L, Blum S. Delusions and the Right Hemisphere: A Review of the Case for the Right Hemisphere as a Mediator of RealityBased Belief. J Neuropsychiatry Clin Neurosci. 2017;29(3):225-35. doi:10.1176/appi.neuropsych.16060118; Perianez JA, Lubrini G, Garcia-Gutierrez A, Rios-Lago M. Construct Validity of the Stroop Color-Word Test: Influence of Speed of Visual Search, Verbal Fluency, Working Memory, Cognitive Flexibility, and Conflict Monitoring. Arch Clin Neuropsychol. 2021;36(1):99-111. doi:10.1093/arclin/acaa034; Petrolini V. When emotion and cognition do (not) work together: Delusions as emotional and executive dysfunctions. Behav Brain Sci. 2015;38:e84. doi:10.1017/S0140525X14000995; Rotarska-Jagiela A, van de Ven V, Oertel-Knochel V, et al. Resting-state functional network correlates of psychotic symptoms in schizophrenia. Schizophr Res. 2010;117(1):21-30. doi:10.1016/j.schres.2010.01.001; Walker DA. JMASM9: Converting Kendall’s Tau For Correlational Or MetaAnalytic Analyses. J Modern Appl Stat Meth. 2003;2(2):525-30. doi:10.22237/jmasm/1067646360; Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175-91. doi:10.3758/bf03193146; Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-76. doi:10.1093/schbul/13.2.261; Eisen JL, Phillips KA, Baer L, et al. The Brown Assessment of Beliefs Scale: reliability and validity. Am J Psychiatry. 1998;155(1):102-8. doi:10.1176/ajp.155.1.102; Ассанович МВ, Ассанович МА. Оценка психометрических характеристик и минимально значимых клинических различий Браунской шкалы оценки убеждений (BABS – Brown Assessment of Beliefs Scale) при шизофрении. Психиатрия, психотерапия и клиническая психология. 2019;10(1):61-8.; Keefe RS, Goldberg TE, Harvey PD, et al. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res. 2004;68(2-3):283-97. doi:10.1016/j.schres.2003.09.011; Саркисян ГР, Гурович ИЯ, Киф РС. Нормативные данные для российской популяции и стандартизация шкалы «Краткая оценка когнитивных функций у пациентов с шизофренией» (BACS). Социальная и клиническая психиатрия. 2010;20(3):13-9.; Stangeland H, Orgeta V, Bell V. Poststroke psychosis: a systematic review. J Neurol Neurosurg Psychiatry. 2018;89(8):879-85. doi:10.1136/jnnp-2017-317327; Wang L, Mruczek RE, Arcaro MJ, Kastner S. Probabilistic Maps of Visual Topography in Human Cortex. Cereb Cortex. 2015;25(10):3911-31. doi:10.1093/cercor/bhu277; Grill-Spector K, Malach R. The human visual cortex. Annu Rev Neurosci. 2004;27:649-77. doi:10.1146/annurev.neuro.27.070203.144220; Nielsen KM, Nordgaard J, Henriksen MG. Delusional Perception Revisited. Psychopathology. 2022;55(6):325-34. doi:10.1159/000524642. Epub 2022 May 19.; Abdel-Hamid M, Brune M. Neuropsychological aspects of delusional disorder. Curr Psychiatry Rep. 2008;10(3):229-34. doi:10.1007/s11920-008-0038-x; DeCross SN, Farabaugh AH, Holmes AJ, et al. Increased amygdala-visual cortex connectivity in youth with persecutory ideation. Psychol Med. 2020;50(2):273-83. doi:10.1017/S0033291718004221; Orliac F, Delamillieure P, Delcroix N, et al. Network modeling of resting state connectivity points towards the bottom up theories of schizophrenia. Psychiatry Res Neuroimaging. 2017;266:19-26. doi:10.1016/j.pscychresns.2017.04.003; Maher BA. Delusional thinking and perceptual disorder. J Individ Psychol. 1974;30(1):98-113.; Hohwy J. Top-Down and Bottom-Up in Delusion Formation. Philosophy, Psychiatry, Psychology. 2004;11(1):65-70. doi:10.1353/ppp.2004.0043; Williams D. Hierarchical Bayesian models of delusion. Conscious Cogn. 2018;61:129-47. doi:10.1016/j.concog.2018.03.003; https://nnp.ima-press.net/nnp/article/view/2026Test

  10. 10
    دورية أكاديمية

    المصدر: Meditsinskiy sovet = Medical Council; № 10 (2023); 163–167 ; Медицинский Совет; № 10 (2023); 163–167 ; 2658-5790 ; 2079-701X

    وصف الملف: application/pdf

    العلاقة: https://www.med-sovet.pro/jour/article/view/7653/6786Test; Jinnah H.A. The Dystonias. Continuum (Minneap Minn). 2019;25(4):976–1000. https://doi.org/10.1212/con.0000000000000747Test.; Berardelli A., Rothwell J.C., Day B.L., Marsden C.D. Pathophysiology of blepharospasm and oromandibular dystonia. Brain. 1985;108(Pt 3): 593–608. https://doi.org/10.1093/brain/108.3.593Test.; Jankovic J. Treatment of hyperkinetic movement disorders with tetrabenazine: a double- blind crossover study. Ann Neurol. 1982;11(1):41–47. https://doi.org/10.1002/ana.410110108Test.; Grandas F., Elston J., Quinn N., Marsden C.D. Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry. 1988;51(6):767–772. https://doi.org/10.1136/jnnp.51.6.767Test.; Tolosa E., Martí M.J. Blepharospasm- oromandibular dystonia syndrome (Meige’s syndrome): clinical aspects. Adv Neurol. 1988;49:73–84. Available at: https://pubmed.ncbi.nlm.nih.gov/3278555Test/.; Zoons E., Dijkgraaf M.G., Dijk J.M., van Schaik I.N., Tijssen M.A. Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco- therapeutic and pharmaco- economic value. J Neurol. 2012;259(12):2519–2526. https://doi.org/10.1007/s00415-012-6510-xTest.; Jankovic J., Havins W.E., Wilkins R.B. Blinking and blepharospasm. Mechanism, diagnosis, and management. JAMA. 1982;248(23):3160–3164. https://doi.org/10.1001/jama.1982.03330230060037Test.; Tucha O., Naumann M., Berg D., Alders G.L., Lange K.W. Quality of life in patients with blepharospasm. Acta Neurol Scand. 2001;103(1):49–52. https://doi.org/10.1034/j.1600-0404.2001.00109.xTest.; Logroscino G., Livrea P., Anaclerio D., Aniello M.S., Benedetto G., Cazzato G. et al. Agreement among neurologists on the clinical diagnosis of dystonia at different body sites. J Neurol Neurosurg Psychiatry. 2003;74(3):348–350. https://doi.org/10.1136/jnnp.74.3.348Test.; Albanese A., Bhatia K., Bressman S.B., Delong M.R., Fahn S., Fung V.S. et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013;28(7):863–873. https://doi.org/10.1002/mds.25475Test.; Albanese A., Sorbo F.D., Comella C., Jinnah H.A., Mink J.W., Post B. et al. Dystonia rating scales: critique and recommendations. Mov Disord. 2013;28(7):874–883. https://doi.org/10.1002/mds.25579Test.; Feng Y.S., Kohlmann T., Janssen M.F., Buchholz I. Psychometric properties of the EQ-5D-5L: a systematic review of the literature. Qual Life Res. 2021;30(3):647–673. https://doi.org/10.1007/s11136-020-02688-yTest.; Steeves T.D., Day L., Dykeman J., Jette N., Pringsheim T. The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord. 2012;27(14):1789–1796. https://doi.org/10.1002/mds.25244Test.; Kilic-Berkmen G., Defazio G., Hallett M., Berardelli A., Ferrazzano G., Belvisi D. et al. Diagnosis and classification of blepharospasm: Recommendations based on empirical evidence. J Neurol Sci. 2022;439:120319. https://doi.org/10.1016/j.jns.2022.120319Test.; Duarte G.S., Rodrigues F.B., Marques R.E., Castelão M., Ferreira J., Sampaio C. et al. Botulinum toxin type A therapy for blepharospasm. Cochrane Database Syst Rev. 2020;11(11):CD004900. https://doi.org/10.1002/14651858.CD004900.pub3Test.; Scorr L.M., Cho H.J., Kilic-Berkmen G., McKay J.L., Hallett M., Klein C. et al. Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review. Dystonia. 2022;1:10359. https://doi.org/10.3389/dyst.2022.10359Test.; Hwang W.J. Demographic and clinical features of patients with blepharospasm in southern Taiwan: a university hospital- based study. Acta Neurol Taiwan. 2012;21(3):108–114. Available at: http://www.ant-tnsjournal.com/Mag_Files/21-3/002.pdfTest.; Wakakura M., Yamagami A., Iwasa M. Blepharospasm in Japan: A Clinical Observational Study From a Large Referral Hospital in Tokyo. Neuroophthalmology. 2018;42(5):275–283. https://doi.org/10.1080/01658107.2017.1409770Test.; Huang X.F., Wang K.Y., Liang Z.H., Du R.R., Zhou L.N. Clinical Analysis of Patients with Primary Blepharospasm: A Report of 100 Cases in China. Eur Neurol. 2015;73(5-6):337–341. https://doi.org/10.1159/000381707Test.; Peckham E.L., Lopez G., Shamim E.A., Richardson S.P., Sanku S., Malkani R. et al. Clinical features of patients with blepharospasm: a report of 240 patients. Eur J Neurol. 2011;18(3):382–386. https://doi.org/10.1111/j.1468-1331.2010.03161.xTest.; Jinnah H.A. Medical and Surgical Treatments for Dystonia. Neurol Clin. 2020;38(2):325–348. https://doi.org/10.1016/j.ncl.2020.01.003Test.; Simpson D.M., Hallett M., Ashman E.J., Comella C.L., Green M.W., Gronseth G.S. et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016;86(19):1818–1826. https://doi.org/10.1212/WNL.0000000000002560Test.; Jankovic J. Botulinum toxin: State of the art. Mov Disord. 2017;32(8):1131–1138. https://doi.org/10.1002/mds.27072Test.; Hassell T.J.W., Charles D. Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins. Toxins (Basel). 2020;12(4):269. https://doi.org/10.3390/toxins12040269Test.; https://www.med-sovet.pro/jour/article/view/7653Test